Sponsor or institution
Clinical trials and research at University of Melbourne
As of November 12, 2026, Find a Trial lists 13 clinical trials run by University of Melbourne that are recruiting, at sites in 14 countries (most in Australia (13), New Zealand (2), France (2)). By phase: Phase 2/3 (2), Phase 4 (1), Phase 1/2 (1). There are also 25 NIH-funded research projects at this institution, with $7.8 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 13Clinical trials
- 25NIH research projects
- 14Countries
Newest trials
All recruiting trials (13)
-
Creating a risk assessment tool for thunderstorm asthma (CARISTA)
This project will test whether lung tests, allergy blood markers and daily symptom tracking can predict which adults with hay fever in South‑Eastern Australia will have seasonal or thunderstorm-related asthma attacks over two spring seasons.
-
Cross bracing versus early ACL reconstruction for recent ACL rupture
This will try whether a 12-week cross bracing program plus supervised physiotherapy helps people aged 16–40 with a recent complete ACL tear more than early ACL reconstruction surgery.
-
Comparing a low-FODMAP diet program versus exposure-based cognitive behavioral therapy for people with IBS
This project will test whether an online low-FODMAP diet program or an online exposure-based cognitive behavioral therapy better reduces IBS symptoms in adults.
-
Neurorecovery program to improve breathing and arm function after spinal cord injury
This program will test whether combining short bouts of lowered oxygen (therapeutic intermittent hypoxia) with exercise training can help people with chronic cervical spinal cord injury (tetraplegia) regain breathing and upper‑limb function.
-
Preparing lung cancer patients for surgery with a home program
This study is testing a home program that helps lung cancer patients get stronger and healthier before their surgery through exercise and support from a physiotherapist.
-
Telehealth education program for patients preparing for major cancer surgery
This study tests whether a telehealth education program can help patients getting ready for major lung and abdominal cancer surgeries recover better and avoid breathing problems compared to those who get regular care.
-
Effects of different amounts of mindfulness meditation on well-being
This study is testing if different amounts of mindfulness meditation can improve well-being in healthy adults who haven't meditated much before.
-
Intra-arterial tenecteplase given after thrombectomy for anterior large-vessel ischemic stroke with no-reflow or residual clot
This trial will test whether giving tenecteplase directly into the artery at the end of thrombectomy helps people with anterior large-vessel ischemic stroke treated within 24 hours of symptom onset.
-
Low dose Nivolumab treatment for adults with HIV on antiretroviral therapy
This study is testing if a low dose of Nivolumab can help adults with HIV on medication reduce the virus in their bodies and possibly stop their HIV treatment safely.
-
Evaluating treatments for Staphylococcus aureus bloodstream infections
This study is testing different treatments for people with Staphylococcus aureus bloodstream infections to find out which ones work best to help them recover and live longer.
-
Using sleep studies to improve breathing support in motor neurone disease
This study is testing if using sleep studies can help people with motor neurone disease get better breathing support from non-invasive ventilation to improve their quality of life.
-
Extending treatment options for stroke caused by basilar artery blockage
This study is testing if a new treatment called tenecteplase can help people who have had a stroke from a blocked basilar artery feel better and recover more effectively compared to standard care.
-
Minimally invasive treatment for brain hemorrhage compared to standard care
This study is testing a new, less invasive treatment for brain bleeding to see if it works better than standard care for patients who arrive at the emergency room with a significant hemorrhage.
NIH-funded research (25)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Understanding how hypoglycemia awareness changes in adults with type 1 diabetes and how automated insulin delivery and exercise might help restore it
This study will look at adults with type 1 diabetes to see how their awareness of low blood sugar evolves over time and whether automated insulin delivery and high-intensity exercise can help restore that awareness.
-
Predicting outcomes in teens at high risk for psychosis (PRESCIENT)
This project follows teens at high risk for psychosis to build better tools that predict who may develop psychosis or related outcomes.
-
PRESCIENT: Predicting Psychosis risk in High-Risk Youth
This project aims to improve early prediction of psychosis in teens and young adults at high risk using multiple biomarkers and clinical data to guide prevention.
-
Predicting psychosis risk in teens using multiple biomarkers and data
This project looks at teens at high risk for psychosis and uses multiple health data pieces to predict who might develop serious symptoms.
-
PRESCIENT: Predicting outcomes in teens at high risk for psychosis
A large international study is tracking teens at risk for psychosis to create and test ways to predict who may develop psychosis and how they’ll fare over time.
-
Predicting psychosis risk in teens at high risk (PRESCIENT)
A study helps teens who are at high risk for developing psychosis by building better ways to predict who might need early help.
-
Predicting Psychosis Risk in Young People (PRESCIENT)
A study to help identify which teens and young adults at high risk for psychosis are most likely to develop serious symptoms, using multiple brain and clinical markers.
-
PRESCIENT: Predicting Psychosis Risk in Adolescents
A long-term study in teens at risk for psychosis uses biomarkers and clinical data to predict who may develop psychosis or related outcomes.
-
PRESCIENT: predicting outcomes in teens at risk for psychosis
A large international effort is building and testing models to predict who among 12- to 20-year-olds at high risk for psychosis will experience meaningful health outcomes.
-
Colon Cancer Family Registry Cohort study for smarter prevention and care
A large international group is following thousands of people with colorectal cancer and their relatives to better understand risk, causes, and outcomes so future patients can get better guidance and treatment.
-
Targeting HIV to remove its footprints by RNA tricks in infected cells
Aims to use CRISPR-based RNA tricks to cut HIV messages and weaken a cell’s survival signals, helping to kill HIV-infected cells in people on ART.
-
Repeated enhanced flu vaccines to boost immunity in older adults
Older adults will receive different enhanced flu vaccines over time to see if repeated vaccination makes their antibodies and T‑cells stronger and more protective.
-
Predicting outcomes for people at high risk of psychosis
This project combines symptoms, brain imaging, biological tests, and other health data to predict future outcomes for young people showing early signs of psychosis.
-
Early signs and future paths for people at high risk of psychosis
This project will build better tools to predict outcomes for young people showing early signs of psychosis.
-
Predicting outcomes for people at high risk for psychosis
This project will develop tools that use symptoms, thinking tests, brain scans, biological markers, and genetics to help predict future mental health outcomes for young people at high risk for psychosis.
-
Predicting outcomes for young people at high risk for psychosis
This project uses clinical information, brain scans, thinking tests, and blood or genetic markers to help predict which young people at high risk for psychosis will develop illness or recover.
-
Predicting outcomes for young people at high risk for psychosis
This project creates tools using medical notes, brain scans, cognitive tests, and genetic information to better predict what will happen to young people showing early signs of psychosis.
-
Predicting pathways for young people at high risk for psychosis
This project aims to create tools that combine clinical, brain imaging, and genetic information to predict which young people at clinical high risk will develop psychosis or other long-term outcomes.
-
Predicting outcomes for young people at high risk for psychosis
This project will build tools to predict which young people with early warning signs of psychosis are likely to develop psychotic disorder or other lasting problems.
-
Understanding how impaired hypoglycemia awareness develops in type 1 diabetes and how automated insulin delivery and exercise might help restore it
This study looks at adults with type 1 diabetes who struggle to sense hypoglycemia and tests whether automated insulin delivery and exercise can help restore their awareness.
-
Predicting outcomes for young people at high risk of psychosis
The team is creating tools that use clinical, brain, and biological data to predict how young people at high risk of psychosis will do over time.
-
Understanding how to improve awareness of low blood sugar in people with type 1 diabetes
This study is looking at how using automated insulin delivery systems and doing high-intensity interval exercise can help adults with type 1 diabetes regain their ability to sense when their blood sugar is low, which is really important for staying healthy.
-
Exploring how sensory networks in the brain work using zebrafish.
This study looks at how zebrafish's brains handle what they see and hear, helping us learn more about sensory processing, which is important for understanding conditions like autism.
-
Creating a detailed 3D map of blood vessels in the mouse urinary tract
This study is looking at how the blood vessels and nerves in the lower urinary tract of mice develop from embryos to adults, which could help us understand how these changes might affect urinary function and related issues.
-
Investigating the effects of repeated influenza vaccinations on immune responses.
This study is looking at how getting the flu shot every year affects the immune system of healthcare workers, to see if frequent vaccinations might make it harder for their bodies to fight off the virus, with the goal of finding better ways to protect everyone from the flu.
Quick answers
How many clinical trials run by University of Melbourne are recruiting right now?
13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in Australia (13 trials), New Zealand (2 trials), France (2 trials), Singapore (2 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 2, Phase 4: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.